Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2003
04/17/2003WO2003030899A2 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
04/17/2003WO2003030891A1 Use of hydroxyoleic acid and similar compounds in the production of medicaments
04/17/2003WO2003030890A1 Immune system activators
04/17/2003WO2003030888A1 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals
04/17/2003WO2003030877A1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer
04/17/2003WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003WO2003030875A1 Over-coated chewing gum formulations including tableted center
04/17/2003WO2003030866A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides
04/17/2003WO2003030857A1 Enhancing epidermal barrier development in skin
04/17/2003WO2003030833A2 Angiopoietin-2 specific binding agents
04/17/2003WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders
04/17/2003WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor
04/17/2003WO2003017927A3 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2003002088A3 Use of an oil of the gourd family for inhibiting 5$g(a)-reductase activity
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2002096903A3 Chemical derivatives and the use thereof as an anti-telomerase agent
04/17/2003WO2002085928A3 Modified cyclosporine which can be used as a pro-drug and use thereof
04/17/2003WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid
04/17/2003WO2002078620A3 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
04/17/2003WO2002076486A3 Histidine-rich glycoprotein
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002069968A8 New use
04/17/2003WO2002058684A3 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
04/17/2003WO2002050289A9 Methods for the production of multimeric proteins, and related compositions
04/17/2003WO2002050284A3 Oxidoreductases
04/17/2003WO2002032960A3 Methods of selecting compounds for modulation of bladder function
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018576A3 Compositions and methods relating to lung specific genes
04/17/2003WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
04/17/2003WO2001078709A3 Treatment of neurodegenerative disease
04/17/2003WO2001076573A3 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
04/17/2003WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same
04/17/2003WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003WO1999056766A3 Method for treating ischemia
04/17/2003US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
04/17/2003US20030073846 Aminoalcohol derivatives
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073833 Antiinflammatory agents; anticoagulants
04/17/2003US20030073820 Hemoglobin conjugate for use in the synthetic blood
04/17/2003US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
04/17/2003US20030073744 Circadian rhythm disorders; sleep disorders
04/17/2003US20030073733 Pharmaceutically active compounds and methods of use
04/17/2003US20030073732 Antiinflammatory agents
04/17/2003US20030073727 Central nervous system disorders
04/17/2003US20030073726 Heterocyclic inhibitors of glycine transporter 2
04/17/2003US20030073725 Naphtalene derivatives and their pharmaceutical use
04/17/2003US20030073724 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073717 Therapy for nervous system disorders; anxiolytic agents; anticonvulsants
04/17/2003US20030073715 Nasal administering; side effect reduction
04/17/2003US20030073714 Prevent drug abruse; side effect reduction; administering mixture of opioid antagonist, releasable form and sequestering agent
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073707 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
04/17/2003US20030073703 Autoimmune disease; antiinflammatory agents
04/17/2003US20030073702 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/17/2003US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073691 Antitumor agents; anticancer agents
04/17/2003US20030073690 Controlling pain in mammals
04/17/2003US20030073686 Anticarcinogenic agents
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073653 Method for transferring nucleic acid into striated muscles
04/17/2003US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
04/17/2003US20030073627 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
04/17/2003US20030073221 Hyaluronan synthase gene and uses thereof
04/17/2003US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition
04/17/2003US20030073118 MID 9002, a human sulfatase family member and uses therefor
04/17/2003US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties
04/17/2003US20030072822 Methods for treating disorders using plant extracts
04/17/2003US20030072808 Immediate release eplerenone compositions
04/17/2003US20030072804 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
04/17/2003US20030072800 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation
04/17/2003US20030072768 Method to enhance an immune response of nucleic acid vaccination
04/17/2003US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions
04/17/2003US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines
04/17/2003US20030072756 Combination therapy using an IL-1 inhibitor and methotrexate
04/17/2003US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve
04/17/2003US20030072737 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
04/17/2003US20030072736 Human tumor necrosis factor receptor TR16
04/17/2003US20030072735 Radiation protecting agent which comprises, as an active ingredient, a mixture of cyclic and/or straight chain poly lactic acids having a condensation degree of 3 to 19
04/17/2003US20030072732 Comprises association between elastase inhibitor compound of the N-acylaminoamide family and at least one antiinflammatory compound; for improving skin ageing and/or photoageing signs by slowing down connective tissue alterations
1 ... 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 ... 1564